FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3157708932> ?p ?o ?g. }

• W3157708932 endingPage "674" @default.
• W3157708932 startingPage "665" @default.
• W3157708932 abstract "NYVEPRIA, a pegfilgrastim (a long-acting granulocyte colony-stimulating factor [G-CSF]) biosimilar, was recently recommended for marketing authorization in Europe for decreasing the incidence of febrile neutropenia (FN) in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs. The present study aimed to evaluate the financial impact of introducing a new pegfilgrastim biosimilar from a French healthcare system perspective.An Excel-based budget impact model was developed to estimate the financial impact by introducing a new pegfilgrastim biosimilar (NYVEPRIA) to France over a 5-year time horizon. Comparators included existing long-acting and short-acting G-CSFs. The burden of FN was obtained from existing literature. Costs (2021 Euros) included drug acquisition and administration, estimated based on drug dosage in both clinical trial and real-world settings. Scenario analyses were conducted to examine the robustness of key model assumptions.In a total French population of 67.19 million, 79,873 patients were estimated to be treated with G-CSFs annually. The annual number of patients to be treated with NYVEPRIA was estimated to be 1593, 3195, 3674, 3782, and 4052 in years 1 to 5, respectively. Using real-world data, NYVEPRIA resulted in total annual cost savings of €8,620, €868,498, €868,498, €814,102, and €958,952 over years 1 to 5, respectively, leading to a cumulative 5-year cost savings of €3,518,669. Using data from clinical trials, NYVEPRIA resulted in total annual cost savings of €14,366, €1,447,496, €1,447,496, €1,356,836, and €1,598,253 over years 1 to 5, respectively, leading to a cumulative 5-year cost savings of €5,864,448.The introduction of a new pegfilgrastim biosimilar (NYVEPRIA) is potentially associated with substantial cost savings for the French healthcare system." @default.
• W3157708932 created "2021-05-10" @default.
• W3157708932 creator A5024580938 @default.
• W3157708932 creator A5041156220 @default.
• W3157708932 creator A5058812106 @default.
• W3157708932 creator A5075668169 @default.
• W3157708932 creator A5084342658 @default.
• W3157708932 date "2021-01-01" @default.
• W3157708932 modified "2023-09-23" @default.
• W3157708932 title "Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data" @default.
• W3157708932 cites W1966875672 @default.
• W3157708932 cites W1969840975 @default.
• W3157708932 cites W1980041456 @default.
• W3157708932 cites W2024933507 @default.
• W3157708932 cites W2057783437 @default.
• W3157708932 cites W2063025360 @default.
• W3157708932 cites W2070320826 @default.
• W3157708932 cites W2084119896 @default.
• W3157708932 cites W2105550105 @default.
• W3157708932 cites W2119679249 @default.
• W3157708932 cites W2123618488 @default.
• W3157708932 cites W2124057396 @default.
• W3157708932 cites W2128953593 @default.
• W3157708932 cites W2163882380 @default.
• W3157708932 cites W2169403306 @default.
• W3157708932 cites W2341045926 @default.
• W3157708932 cites W2400922751 @default.
• W3157708932 cites W2560692010 @default.
• W3157708932 cites W2728227150 @default.
• W3157708932 cites W2749228235 @default.
• W3157708932 cites W2886016690 @default.
• W3157708932 cites W2898022956 @default.
• W3157708932 cites W2901774702 @default.
• W3157708932 cites W2921842455 @default.
• W3157708932 cites W3033563729 @default.
• W3157708932 cites W3048696092 @default.
• W3157708932 doi "https://doi.org/10.1080/13696998.2021.1922252" @default.
• W3157708932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33904357" @default.
• W3157708932 hasPublicationYear "2021" @default.
• W3157708932 type Work @default.
• W3157708932 sameAs 3157708932 @default.
• W3157708932 citedByCount "4" @default.
• W3157708932 countsByYear W31577089322021 @default.
• W3157708932 countsByYear W31577089322022 @default.
• W3157708932 countsByYear W31577089322023 @default.
• W3157708932 crossrefType "journal-article" @default.
• W3157708932 hasAuthorship W3157708932A5024580938 @default.
• W3157708932 hasAuthorship W3157708932A5041156220 @default.
• W3157708932 hasAuthorship W3157708932A5058812106 @default.
• W3157708932 hasAuthorship W3157708932A5075668169 @default.
• W3157708932 hasAuthorship W3157708932A5084342658 @default.
• W3157708932 hasBestOaLocation W31577089321 @default.
• W3157708932 hasConcept C126322002 @default.
• W3157708932 hasConcept C194828623 @default.
• W3157708932 hasConcept C2777063308 @default.
• W3157708932 hasConcept C2778658803 @default.
• W3157708932 hasConcept C2779171977 @default.
• W3157708932 hasConcept C2908647359 @default.
• W3157708932 hasConcept C29730261 @default.
• W3157708932 hasConcept C535046627 @default.
• W3157708932 hasConcept C59491497 @default.
• W3157708932 hasConcept C71924100 @default.
• W3157708932 hasConcept C99454951 @default.
• W3157708932 hasConceptScore W3157708932C126322002 @default.
• W3157708932 hasConceptScore W3157708932C194828623 @default.
• W3157708932 hasConceptScore W3157708932C2777063308 @default.
• W3157708932 hasConceptScore W3157708932C2778658803 @default.
• W3157708932 hasConceptScore W3157708932C2779171977 @default.
• W3157708932 hasConceptScore W3157708932C2908647359 @default.
• W3157708932 hasConceptScore W3157708932C29730261 @default.
• W3157708932 hasConceptScore W3157708932C535046627 @default.
• W3157708932 hasConceptScore W3157708932C59491497 @default.
• W3157708932 hasConceptScore W3157708932C71924100 @default.
• W3157708932 hasConceptScore W3157708932C99454951 @default.
• W3157708932 hasFunder F4320307765 @default.
• W3157708932 hasIssue "1" @default.
• W3157708932 hasLocation W31577089321 @default.
• W3157708932 hasLocation W31577089322 @default.
• W3157708932 hasOpenAccess W3157708932 @default.
• W3157708932 hasPrimaryLocation W31577089321 @default.
• W3157708932 hasRelatedWork W1477177968 @default.
• W3157708932 hasRelatedWork W1982139020 @default.
• W3157708932 hasRelatedWork W2754747062 @default.
• W3157708932 hasRelatedWork W2797890311 @default.
• W3157708932 hasRelatedWork W3010100147 @default.
• W3157708932 hasRelatedWork W3013624574 @default.
• W3157708932 hasRelatedWork W3191523363 @default.
• W3157708932 hasRelatedWork W4249604018 @default.
• W3157708932 hasRelatedWork W4312095771 @default.
• W3157708932 hasRelatedWork W857367169 @default.
• W3157708932 hasVolume "24" @default.
• W3157708932 isParatext "false" @default.
• W3157708932 isRetracted "false" @default.
• W3157708932 magId "3157708932" @default.
• W3157708932 workType "article" @default.